• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

FDA-TRACK Center for Biologics Evaluation & Research

Red envelope icon for Govdelivery Sign up to receive FDA-TRACK email updates

The Center for Biologics Evaluation and Research (CBER) regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. CBER protects and advances the public health by ensuring that biological products are safe and effective and available to those who need them. CBER also provides the public with information to promote the safe and appropriate use of biological products.

-

FDA-TRACK CBER Program Areas and Offices

CBER has three program areas for seven offices. Click on the links below for additional information relating to these program areas and their dashboards.

-
 

Contact FDA

FDA-TRACK

FDA-TRACK Team

OC/OPP/Office of Planning

10903 New Hampshire Avenue

WO32 - Rm. 3357

Silver Spring, MD 20993